GEDEON RICHTER |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.85 USD | +4.85% |
|
-.--% | +4.85% |
| 05-31 | Gedeon Richter Plc. Approves Dividend Payment in Respect of the 2023 Financial Year | CI |
| 05-22 | Gedeon Richter plc announces Directorate Changes | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.85% | 4.57B | - | ||
| +20.37% | 43.54B | B- | ||
| +18.30% | 21.78B | B+ | ||
| +17.66% | 15.38B | - | ||
| +25.55% | 15.12B | B+ | ||
| +60.99% | 13.36B | B | ||
| -0.05% | 6.79B | - | - | |
| -14.84% | 6.38B | B+ | ||
| -8.87% | 5.73B | - | - | |
| +8.17% | 5.32B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- RICHTER Stock
- GEDSF Stock
- Ratings Gedeon Richter
